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Abstract 
The objective of this study is to model the urinary toxicokinetic of cobalt exposure based on 
of 507 urine samples from 16 workers, followed up for one week, and 108 related 
atmospheric cobalt measurements to determine an optimal urinary cobalt sampling strategy at 
work and a corresponding urinary exposure threshold (UET). These data have been used to 
calibrate a population toxicokinetic model, taking into account both the measurement 
uncertainty and intra- and inter-individual variability. Using the calibrated model, urinary 
sampling sensitivity and specificity performance in detecting exposure above the 20 μg/m3 
threshold limit value (TLV-TWA) has been applied to identifying an optimal urine sampling 
time. The UET value is obtained by minimizing misclassification rates in workplace 
exposures below or above the TLV . Total atmospheric cobalt concentrations are in the 5 - 
144 µg/m
3
 range, and total urinary cobalt concentrations are in the 0.5 - 88 µg/g creatinine. A 
two-compartment toxicokinetic model best described urinary elimination. Terminal 
elimination half-time from the central compartment is 10.0 hours (95% confidence interval 
(8.3 - 12.3)). The optimal urinary sampling time has been identified as 3 hours before the end 
of shift at the end of workweek. If we assume that misclassification errors are of equal cost, 
the UET associated with the TLV of 20 µg/m
3
 is 5 μg/L which is lower than the ACGIH 
recommended BEI® of 15 μg/L. 
Introduction 
Cobalt (Co) enters into the composition of hard metal alloys used in electrical, aeronautical or 
car industries as a binder for metallic carbides (tungsten, silicon, vanadium). Cobalt  enhances 
the resistance of these alloys to high temperatures and corrosion. Cobalt is also used in steel 
production, glass and ceramic industries, and many other industrial applications. All 
personnel working in these industries are potentially exposed to cobalt or its compounds, both 
of which can induce chronic intoxication leading to respiratory, thyroid, cutaneous, cardiac 
and carcinogenic effects (1-5) under some circumstances. 
 The American Conference of Governmental Industrial Hygienists (ACGIH) has 
defined two exposure indices applicable to cobalt occupational exposures (6): an atmospheric 
threshold limit value time weighted average (TLV-TWA) of 20 µg/m
3
 and a biological 
exposure index (BEI®) of 15µg/L total  cobalt concentration in urine collected at the end of 
shift at the end of the last day of the workweek. The ACGIH has justified this BEI® through 
four studies (7-10) giving linear regression equations between cobalt concentration in ambient 
air and in urine obtained at the end of shift at the end of the workweek. In each of those 
studies, the regression equation was used to estimate cobalt levels in urine at 20 µg/m
3
 
exposure, assuming the TLV value to be reliable. No data on exposure or urinary cobalt were 
available before the last shift, except in one study (7). Thus the potential effect of cobalt 
exposure during the preceding days could not be assessed. Furthermore, in the absence of 
accurate information on cobalt excretion kinetics and of inter-individual variability, it is 
unclear whether urinary collection at the end of shift at the end of workweek is indeed the best 
sampling time. The BEI® value obtained from a linear regression equation is itself certainly 
not optimal because it ignores both the time-dependency of relationship between airborne 
exposure and urinary cobalt and the very large inter-subject variability. 
 This paper presents a toxicokinetic approach for determining an optimized urinary 
sampling strategy for cobalt and a consistent way of deriving an urinary exposure threshold 
(UET),  corresponding to the ACGIH BEI®, for use in occupational hygiene. A population 
toxicokinetic model of cobalt intake and urinary excretion was developed from data on a 
series of cobalt-exposed subjects followed up during a period of one week. Atmospheric and 
urinary cobalt measurements were simultaneously collected for each subject. The model was 
then applied predictively to identify an optimal sampling strategy and back-calculate a UET 
corresponding to the current value of the TLV, which is assumed to provide valid protection 
for exposed workers. 
Population and Methods 
Population 
 A total of 16 male subjects exposed to cobalt dust were recruited in two plants 
producing tungsten carbide cutting tools. They were followed-up during one workweek 
respectively in 1988 and 1993. 
Atmospheric and urinary sampling strategy 
 Airborne exposure to cobalt was measured by sampling the inhalable dust fraction in 
each individual breathing zone for all work shifts during the study week. The workweek 
comprised four, five or six days, depending on the plant and the subjects. For most subjects, 
exposure was measured for each half-shift (mean duration of half-shift = 3.5 hours), and for 
the others, exposure was measured for the total shift (mean of total shift = 7.5 hours).  
 Airborne sampling was performed in compliance with French AFNOR standard  NF X 
43457. Aerosol samples were collected on WHATMAN® QM-A quartz fibre filters fitted in 
closed configuration inside a MILLIPORE 37 mm cassette designed to collect the aerosol 
inhalable fraction by means of GILIAN® HFS113 (1 L/min flow) portable sampling pumps. 
The personal pump flow rate was carefully checked at the beginning and end of each 
sampling sequence. The flow rate was also regularly checked at intermediate times. 
 All urine voiding of the study week were collected in parallel for each subject. Each 
subject was informed of the study aims and conditions, and agreed to collect urine based on a 
controlled sampling procedure: Subjects were requested to collect urine samples whilst 
avoiding contamination, without working clothes, with clean hands and, if possible, after a 
shower at the end of shift. The urine was processed, packaged and frozen on site. All 
equipment cups and tubes in contact with the urine for analysis were previously washed with 
a hot detergent, rinsed and immersed for 48 hours in a 10% nitric acid solution , rinsed with 
ultra-pure water and dried in a oven at 50°C. All these operations as well as storage were 
performed in airtight polyethylene containers, in which all devices were protected from dust 
and contact with operator fingers. Each urine sample was analyzed separately. For 12 
subjects, all voiding of the following weekend were also obtained and analyzed. 
Analytical methods 
Air sample analysis 
 Total cobalt content of the filters was analyzed by two laboratories with a method 
developed by one of them (11). These laboratories belong to the French inter-laboratory ring 
trial network for occupational hygiene. Particles deposited on each filter, including dust on the 
filter holder inner walls, were dissolved in mixture of hydrofluoric (2 mL, 40%) and nitric (3 
mL, 68%) acids. Cobalt was measured at a wavelength of 240.7 nm by atomic absorption 
spectrophotometry, using a flame technique based on a 10 µg/L detection limit. 
Urine sample analysis 
 Total urinary cobalt concentration was evaluated by electrothermal atomic absorption 
spectrometry using a Perkin Elmer 3030/Zeeman instrument based on a method (12) 
involving a detection limit of 2 nmol/L ≈ 0.1µg/L in INRS internal quality system. 
 Urinary creatinine was determined by colorimetry (Roche 3667 kit) using a Cobas 
Mira S Plus (Roche Diagnostic System). 
Statistical methods 
 A number of urine sampling strategies were compared on the basis of their efficiency 
at detecting an atmospheric cobalt concentration higher than a limit value. Optimal sampling 
was determined based on results of a multilevel (population) toxicokinetic data modeling (13), 
which estimates jointly the toxicokinetic parameters of each subject (subject level) and the 
inter-worker distribution of these parameters (population level). 
Population toxicokinetic model 
 Figure 1 shows a conceptual graph of this model. 
 At the subject level, a toxicokinetic approach was used to model the urine-excreted 
quantity of cobalt in each voiding for each subject, as a function of the time-dependent 
atmospheric cobalt concentration in the worker’s breathing zone, and of the urine sampling 
time. 
 All urine voiding were collected and analyzed separately. The absolute quantity of 
cobalt (in µg) excreted at each voiding was modeled as the dependent variable. This quantity 
was obtained by multiplying the cobalt concentration by the corresponding volume of 
excreted urine. Thus, this process overcame the need to use cobalt expressed per g creatinine. 
For each subject, the time course of cobalt quantity in urine (Qu) was modeled as the output of 
a deterministic two-compartment model. This model included a central compartment and a 
peripheral one, both without particular physiological interpretation. We checked that a simpler 
1-compartment model would not correctly predict the data (results not shown). We also 
checked different parameterizations using various distribution shapes (see the Discussion 
section). The toxicokinetic model for each subject i had four transfer parameters θi = {Kin, Kr, 





 are not displayed on Figure 1 for clarity). The mathematical model and the precise 
meaning of these parameters are provided in online appendix 1.
 
The toxicokinetic model can 
be viewed as a function relating cobalt urinary excretion to air exposure, time, and 
toxicokinetic parameters for a given subject: 
 Qu = f(Cin, t, θi) (1) 
 At the population level, subjects were assumed to differ randomly from each other. 
The 4-component parameter vectors θi characterizing each subject were assumed to be log-
normally distributed in the population: 
 Log(θi) ~ Normal(μ, Σ) (2) 
in which μ and Σ were respectively the population mean and variance (themselves vectors of 
four elements each, the variance measuring inter-individual variability) in a logarithmic scale. 
 At the measurement level, both cobalt concentration in air Cin and urine cobalt 
quantity Qu were measured at finite accuracy. A measurement error model, assumed 
applicable to all subjects, was therefore set up to account for uncertainties affecting those 
data. We assumed that Cin was measured with a multiplicative log-normal error with GSD 1.5 
(implying a 95% chance that the measured value was between 0.5 and twice the true value) 
(see the discussion for a justification of that model). The analytical measurement errors 
around Qu were assumed to follow a normal distribution with mean zero and a standard 
deviation, ξ, modeled as the sum of a constant error term SDmin and a term proportional to Qu 
(eq. 3): 
 CoVQSD u ⋅+= minξ  (3) 
 When Qu is close to zero, ξ is at least equal to SDmin and, for high values of Qu, that 
equation approximates a relative error model. The proportionality term (CoV) can be 
interpreted as a coefficient of variation.  
 All the parameters of the above models (θi, μ, Σ, CoV, SDmin) were estimated in a 
Bayesian framework. Because for most parameters little prior information was available 
(mostly that they are non-negative and their order of magnitude), their prior distributions were 
chosen so that they had little influence on the final result (see online appendix 2). These prior 
distributions were then updated on the basis of the data to obtain posterior distributions, which 
were the Bayesian equivalent of estimated parameter and confidence intervals. Updating 
required calibration of the entire statistical toxicokinetic model with urinary and atmospheric 
cobalt concentrations data measured for the 16 subjects. Markov Chain Monte-Carlo 
(MCMC) methods (14-15) were applied using MCSim software (Free Software Foundation, 
Boston, MA, “http://www.gnu.org/software/mcsim/”). Two parallel Monte-Carlo Markov 
Chains with different starting points were run. After 10000 iterations, the two chains mixed 
well and converged, according to the R criterion of Gelman and Rubin (1992) (16). The 
following 50000 iterations of the two chains were used for identifying the posterior 
distribution. Model fit was checked and its predictive properties were tested by cross-
validation (details on priors and model checks given in online appendix 2). 
Determining an optimal sampling strategy 
 To determine the optimal strategy, we randomly sampled the toxicokinetic parameters 
for 200 virtual individuals from the posterior population distributions obtained as described 
above. Each of these virtual individuals was exposed to a cobalt given dose for one workweek 
(four 8-hour shifts). This dose was assumed to be equal for all shifts. For each subject, a series 
of 28 atmospheric cobalt exposures was set, with exposure concentrations between 5 μg/m3 
and 30 μg/m3 in steps of 1 μg/m3, plus 35 and 40 μg/m3. Thus 12 of the 28 exposure 
simulated exceeded the 20 μg/m3 TLV.  
 For each of the 200 simulated subjects and 28 possible exposure levels, five urinary 
sampling strategies (USS) were compared: (A) Three hour urines collected each day at the 
shift end, and averaged over four workdays; (B) Three hour urines collected each day after 4 
hours of exposure, and averaged over four workdays; (C) First urine of the last day of the 
workweek; (D) Urine from the last 3 hours of the last shift of the week; (E) Urine from the 3 
hours following the end of the last shift of the week.  
 For any USS, the excretion rate of cobalt in urine was simulated every hour and the 
cobalt content of voiding, assumed to take place every three hours (close to the observed 
mean duration), were computed. A random error was added to that quantity based on the 
above urinary measurement error model (eq. 3). Predicted cobalt quantities were transformed 
into urinary cobalt concentrations by dividing them by 237 mL, the mean observed volume 
among the study subjects. That procedure takes into account the dependence of cobalt 
concentrations (inside the body and in urine) on the toxicokinetic parameters of each 
individual, and on the time-varying exposure (cobalt concentrations increase nonlinearly 
during exposure and decrease in the absence of exposure).  
 USS were compared according to their sensitivity and specificity in detecting an 
atmospheric value above a TLV of 20 μg/m3. For each USS, a receiver operating 
characteristic (ROC) curve, giving the sensitivity for detecting above TVL excursions as a 
function of (1 minus specificity), was constructed by varying the urinary exposure threshold 
(candidate UET) by steps of 0.25 μg/L between 0 and 9 μg/L and by steps of 1 μg/L between 
10 and 20μg/L. For any given value of that threshold (say 8 μg/L), the sensitivity was 
computed as the number of simulated urinary concentration values exceeding 8 μg/L, divided 
by the number of simulations for atmospheric exposures equal or superior to the 20 μg/m3 
TLV (n=13x200=2600). Similarly, the specificity was computed as the number of simulated 
urinary concentration values below 8 μg/L, divided by the number of simulations for 
atmospheric exposures below the 20 μg/m3 TLV (n=15x200=3000). The best USS was taken 
as the one with the largest area under the ROC curve (17). 
 After determining the optimal USS, the final step was to establish an optimal UET 
value for comparing future urinary results. For each candidate UET, each of the 5600 values 
of the USS-specific urinary measurements was either well-classified (both the atmospheric or 
urinary are either below or above their respective limits), or falsely positive (i.e., with an 
urinary value above the UET with an atmospheric exposure below the TLV) or falsely 
negative (i.e., with an urinary value below the UET with an atmospheric exposure above the 
TLV). We denote by CFP the cost associated with a false positive classification, CFN the cost 
associated with a false negative classification and  FP and FN, respectively, the number of 
false positives and false negatives in our sample of 5600 values. Denoting by C= CFP /(CFN + 
CFP), the relative cost of false positives over all false classifications, each value of the UET 
was  associated with a total cost, given by: 
Total Cost= CxFP+(1-C)xFN 
 A large UET resulted in wrongly classifying high urinary exposures as acceptable 
(large FP and low FN) while a small UET resulted in wrongly classifying low exposures as 
unacceptable (large FN and low FP). Increasing C, i-e increasing CFP whilst keeping CFN 
constant, would lead to put more emphasis on the costs associated with  wrongly deciding that 
the atmospheric exposure exceeds the TLV based on the urine sample, while decreasing C 
would put more emphasis on the protection of the worker. The optimal UET among the 




 The atmospheric and urinary measurements for each of the 16 subjects studied are 
summarized in Table 1. The geometric mean of the atmospheric cobalt exposure 
measurements of plant A (subjects A to G) exceeded the TLV of 20 µg/m3 defined by the 
ACGIH in 3 out of 7 subjects. In plant B (subjects 1 to 9), the geometric means of the 
atmospheric cobalt measurements were even higher. Atmospheric cobalt exposures for each 
subject were usually followed by a peak in urinary cobalt within the next hours, which 




 The 2-compartment model gave a relatively close data fit, with model predictions 
following the described previously concentration time-course pattern. We chose the best 
model among the different ones we tested using different priors and distribution shapes. 
Those made little difference, but as soon as we chose a two-compartment model, the model fit 
improved markedly and did not depend much on the distributional shapes and priors we used. 
The overall correlation between observed data and model predictions is given in online 
appendix 2. Figure 2 illustrates in detail the fit for subject A. To provide a more familiar 
representation of the kinetics illustrated in Figure 2, all urinary measurements and predictions 
(urinary quantities in µg) were divided by time elapsed since the previous urine collection. 
This led to an expression of the urinary cobalt excretion flow in µg/h. Table 2 presents a 
summary of the posterior distributions of population and individual model parameters.  
 The population geometric mean of Kin  characterizing the quantity of inhaled cobalt 
entering the organism per unit time, was estimated at 60.4 L/h with a between-subject GSD of 
2.0. Elimination parameter Ke corresponds to an elimination half-time Te1/2 of approximately 
10 hours, varying between 8 and 12 hours relatively constant for the studied subjects 
(GSD=1.16). Half-times Tr1/2 and Ts1/2 corresponding to exchanges with the peripheral 
compartment, were estimated at 9 and 20 hours respectively, with a rather high inter-
individual variability. The coefficient of variation (CoV) for the urinary cobalt measurements 
was estimated at about 36% (CI 95%: 32% to 40%), with a baseline SDmin of 0.03 µg/voiding 
(CI 95%: 0.002 to 0.08)  
Optimal sampling strategy 
 Detailed comparisons of the various strategies, on the basis of ROC curves, are 
presented in the online appendix 3. The best sampling strategies were to collect urine sampled 
during the last 3 hours of the last shift of the week (USS D) or during the 3 hours following 
the end of the last shift of the week (USS E). For ease of sampling, urine sampling from the 
last 3 hours of the last weekly shift can be considered as the optimal sampling strategy. 
 Figure 3 illustrates cost functions for two misclassification costs, C. The heavy line 
represents the cost associated with a false positive (FP, wrongly deciding that the exposure 
exceeds the TLV) and a false negative (FN, wrongly deciding that the atmospheric exposure 
is below the TLV). These were set to the same value, meaning that the user gave as much 
importance to an FN as to an FP (C = 0.5 and CFN=CFP). The optimal UET value is 5 µg/L in 
that case. For the exposure values considered and given the chosen optimal USS, this UET 
yields an FP percentage of 40% and of an FN percentage of 23%. For the light line, the cost of 
FN was considered to be twice  as high as that of FP meaning that the user gave twice as 
much importance to an FN as to an FP (C = 0.33 and CFN = 2CFP). The optimal UET was then 
approximately 3.5 µg/L, yielding 58% FP and 12% FN. 
Discussion 
 This paper presents an optimized strategy for urinary sampling in the workplace based 
on a population toxicokinetic modeling of the urinary cobalt excretion kinetics in 16 workers 
over a period of one week. We find that the optimal strategy was to sample urine during the 
last three hours of the workweek. In implementing this strategy, we have calculated a UET 
value corresponding to the TLV of 20 µg/m
3 
depending on costs assigned with wrong 
decisions. A UET value of 5 µg/L is obtained when the cost of wrongly deciding that 
exposure is acceptable is considered equal to the cost of deciding that the exposure is 
unacceptable. Our results agree with international recommendations (6) with respect to the 
urinary sampling time (end of shift at the end of workweek). They also suggest that sampling 
after the end of shift at the end of workweek would not provide any additional benefit.  
 However, the optimal biological value (UET) we obtained (5μg/L or 3.5 μg/L, 
depending on the error relative cost) is lower than the value (15 μg/L) recommended by the 
ACGIH. When applying the 15 μg/L value, we estimated 80% of false negatives (that is, 
workers with urinary cobalt concentrations below the UET during exposure atmospheric 
concentrations exceeding the TLV), and 3.5% of false positives (data not shown). The high 
percentage of false negatives shows that the ACGIH BEI® may not sufficiently protect the 
workers. The difference depends probably to a large extent on how correspondence between 
TLV and BEI® was established. The ACGIH have used only cross-sectional end-of-shift 
urinary data linearly regressed on the atmospheric exposure. Most notably, no individual 
kinetics were observed. Conversely, our results stem from modeling of actual individual data 
for workers followed-up over a full week. It should be noted (data not shown) that, if we 
apply the ACGIH strategy to our data with a simple linear regression, the corresponding value 
of the UET is 15 µg/L when we regress urinary concentration on the log atmospheric 
concentration in the last shift of the workweek, and is 12 µg/L when using atmospheric 
concentration on the natural scale. If we apply the ACGIH strategy to our data, we obtain an 
UET close to the BEI®. However, our data and method also allow to actually estimate 
misclassification rates and, allowing for them, yield a much lower UET. This is largely due to 
the fact that our approach takes inter-worker variability into account; the ACGIH approach 
does not do this explicitly. Thus our results represent a challenge not only to the BEI® for 
cobalt, but, more generally, to the ACGIH  approach to deriving these BEI®s.  
 Our results may be discussed in relation to a number of issues. We did not consider 
varying volume of voiding when determining an optimal strategy and the corresponding UET. 
However, we do not believe that this is a serious limitation. What was measured, and used as 
data to calibrate the model, is the cobalt quantity in µg in each voiding. That quantity depends 
on the time between voiding (the voiding times were recorded and those actual times were 
used in input to the model). The urine volume also depends on time between voiding, but the 
quantity excreted between two voiding is conditionally independent of the urine volume given 
the voiding times. However, we used the mean volume observed among our subjects, when 
converting this quantity into a concentration in µg/L, for display purposes.. If we wanted to 
ensure protection for all workers, we would need  to use a minimum urine volume and this 
would lead to even higher concentrations.  
 All urines of the week were collected and atmospheric exposure was measured for all 
the shifts worked. The range of cobalt urinary and atmospheric concentrations was very wide 
(geometric mean from 4.89 to 144.22 µg/m
3
 for atmospheric data, and from 1.62 to 12.33 
µg/g creatinine for urinary data). The range of applicability of our results should therefore be 
relatively wide too. Moreover, the total number of workers (16) studied is not very large, but 
for each worker all exposure and urinary follow-up is complete.   
 The model estimates at 36% the coefficient of variation of the urine analytical cobalt 
concentration measurement . This is higher than the laboratory value, supposedly to be 4% 
(12). We therefore confirm that the true accuracy of field studies is probably lower than pure 
laboratory uncertainty. However, the estimated 36% CV also includes other sources of errors 
(modeling error or intra-individual variability) and represents an upper limit in terms of 
analytical accuracy. 
 Atmospheric exposures measurements were collected over half shifts or complete 
shifts because instantaneous readings were not feasible. Therefore, in contrast to usual 
pharmacokinetic modeling, only mean exposures values were available in this case. This 
created a degree of uncertainty in the estimated parameters. Secondly, atmospheric 
measurements cannot be assumed to correspond exactly to the inhaled quantity. This was 
taken into account by assuming a log-normal measurement error with GSD 1.5 around the 
true inhaled concentration value. Other GSDs between 1.2 and 2 were tried, but  the model’s 
overall fit did not change much and that had no influence on the UET. Only one model is 
presented in this paper. However, alternative toxicokinetic models were considered and fitted, 
including one-compartment models and other parameterization of the measurement sub-
models. For instance, several different prior statistical distributions were tested. The model 
shown here was chosen because of its better fit to the data. 
 The parameters of our model are subject to only limited physiological interpretation. 
The elimination half-time Te1/2 (equivalent to rate constant Ke) can be interpreted as the body 
elimination half-time of cobalt (central compartment). The parameters determining flow rates 
between the central compartment and other non-specified organs (lumped into a single 
peripheral compartment) cannot be  easily interpreted. The estimated geometric mean for Kin, 
the parameter determining the cobalt quantity inhaled into the organism per unit time, is 60.4 
L/h. That is quite lower that the physiological respiratory flow rate, which is about 500 L/h 
for a man at rest. A possible explanation for this is that 88% (1-(60.4/500)=0.88) of the 
inhaled cobalt is exhaled or does not enter the body (i.e. is eliminated by the lungs into the 
gastro-intestinal tract and feces without absorption). It has been estimated that approximately 
30% of cobalt inhaled as cobalt oxide can be absorbed (18). 
 It is interesting to note that, when  a single compartment model was applied (data not 
shown), the estimated parameter Kin was virtually identical to the one estimated in the two-
compartment model. Elimination half-time from the one-compartment model was 
approximately 20 hours (data not shown), which is close to the values given by Lauwerys and 
Hoet (19) (p88) quoting Christensen  et al (20) and Apostoli et al (21). In the two-
compartment model, the apparent elimination time depends on the rate-limiting exit from the 
peripheral compartment rather than on  the elimination from the central compartment. But 
here also , the elimination half-life is estimated at approximately 20 hours (Ts1/2=20.38 hours) 
whilst the 2-compartment model fit to the data was far better than that of a one-compartment 
model.  
 The results given in this paper were based on a large number of data (507 urinary 
cobalt determinations and 108 atmospheric cobalt measurements), requiring very close co-
operation of the study subjects and availability of research personnel for every working shifts 
during the week. Such a protocol is expensive and difficult to organize. Therefore, it should 
only be used if its results are expected to be interpretable and useful. An important constraint 
in this respect is the elimination half-time. If it is longer than a few days, this procedure 
involving atmospheric and urinary data for a whole week will not allow it to be accurately 
identified it with any precision, yet it would still condition the overall body burden. Thus for 
metals with a longer elimination half-time, this protocol would be unsuitable. A similar 
protocol with sparser sampling over a longer period of time would be more appropriate. 
Optimal design methods could be applied to this issue (22). Lauwerys and Hoet (19) suggest 
there is another component (possibly due to kidney or liver storage) of cobalt kinetic, which 
may persist  for 2 years. The protocol applied in this study would naturally be incapable of 
identifying  phase associated with such a compartment. However, for all practical purposes in 
occupational health, two compartments described the data  and simulations closely enough 
(data not shown), showing that a dynamic steady-state is  reached.  
 On the other hand, we should note a number of limitations on the possibility of 
extrapolating our study results. First, despite the wide range of exposure levels, all data were 
obtained in hard metal factories at which cobalt was always combined with tungsten. It cannot 
be assumed that the results would be exactly the same in other forms of cobalt exposure 
(coating, recycling, ceramics, polymers). However, the data do originate from two different 
plants, which contributes to our confidence in  results representative of such this form of 
occupational exposure. It is known that the close-faced cassette sampler is slightly biased in 
relation to the ISO curve. However, the exposure is never overestimated so the low 
percentage of cobalt retained in the body cannot be explained by this bias. Furthermore, this 
study assumes that all the cobalt intake is via inhalation. It is probable that some intake is via 
ingestion, on which we have no information (19). However, the low percentage of cobalt 
retained in the body does not support the hypothesis of a major impact from a source of 
exposure other than the respiratory. A final limitation of our study is that no physiological 
data were available on the subjects (e.g., respiratory flows, smoking habits and so 
on).Therefore, individual characteristics could not be taken into account using, for example, a 
physiologically-based pharmacokinetic model. However, this may not be central issues, given 
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TABLE I. Summary statistics of the atmospheric and urinary cobalt concentration data in µg/g crea and in µg/L. 

























    
µg/g crea 
GSD 
(B) Min    
µg/g crea












A 4 8 4.9 1.4 4 9 7 35 1.6 2.1 0.5 21.9 2.3 2.3 0.5 22.7 
B 4 8 9.4 1.6 4 18 7 34 3.6 1.7 0.6 8.4 5.7 2.2 1.2 20.7 
C 4 8 10.7 1.4 7 16 7 34 2.9 1.9 1.0 7.8 3.9 2.2 0.8 16.4 
D 4 8 6.2 1.8 4 17 7 33 2.5 1.8 0.8 6.2 2.7 2.2 0.2 10.1 
E 4 8 61.6 2.8 22 276 7 34 12.3 2.3 1.9 87.9 14.3 2.7 2.0 197.8 
F 4 8 26.3 1.2 20 32 7 36 6.0 1.6 2.5 13.1 8.1 2.2 1.4 30.2 
G 4 8 25.6 2.0 10 74 7 35 4.2 2.1 1.2 16.4 4.9 2.2 1.2 38.4 
1 5 10 144.2 2.0 66 449 7 34 16.4 1.9 5.4 65.1 14.5 1.9 1.8 47.7 
2 4 4 26.9 3.4 6 72 4 25 11.5 2.2 1.9 55.1 15.5 2.3 2.0 71.0 
3 6 6 41.8 2.9 17 228 7 34 8.6 2.0 3.0 69.7 5.7 2.4 0.3 34.8 
4 6 6 74.5 2.8 21 205 7 34 11.4 1.6 5.2 28.6 15.0 1.5 7.1 43.5 
5 5 5 14.8 2.9 6 72 4 25 4.5 1.5 2.1 12.7 6.6 1.7 2.0 15.8 
6 5 5 19.8 1.3 14 25 7 29 8.7 1.6 2.9 20.2 9.6 1.5 3.7 22.1 
7 5 5 26.8 1.8 18 77 4 26 7.5 1.7 2.2 13.8 7.2 1.5 3.2 16.6 
8 5 5 23.3 1.6 12 35 4 25 7.2 1.7 2.6 15.9 10.0 1.3 5.6 19.1 
9 6 6 5.9 2.0 3 19 7 34 3.0 1.7 1.1 8.0 2.6 1.9 0.3 6.9 
(A) GM = Geometric Mean 




TABLE II. Summary statistics of the posterior distributions for population and individual parameters. 
Parameter (unit) 
Population geometric 
mean  µ   (95% CI) 
Between subject 
geometric SD Σ 
(95% CI) 
Minimum of mean  
subject-specific 
value (subject) 






60.4 (27.3-97.3) 2.04 (1.47-4.57) 29.9 (1) 123 (D) 
Ke (1/h)
(B) 0.068 (0.056-0.083) 1.16  (1.02-1.54) 0.059 (F) 0.076 (9) 
Te1/2 (h)
(C) 10.19 (8.35-12.37) 1.16  (1.02-1.54) 11.75 9.12 
Kr (1/h)
(D) 0.078 (0.040-0.25) 1.93  (1.15-4.89) 0.054 (G) 0.171 (8) 
Tr1/2 (h)
 (C) 8.88 (2.77-17.32) 1.93  (1.15-4.89) 12.8 4.0 
Ks (1/h)
(D) 0.034 (0.013-0.10) 2.22  (1.17-4.98) 0.015 (3) 0.117 (1) 
Ts1/2 (h)
 (C) 20.38 (6.93-57.76) 2.22  (1.17-4.98) 46.2 5.92 
 
(A)
 Kin: intake coefficient 
(B)
 Ke : elimination coefficient 
(C) 
 Tx1/2 = half time = ln(2)/Kx
(D)
 Kr and Ks : transfer coefficients between central and peripheral compartment, (see online appendix 2 and text). 
 
 
APPENDIX - Occupational Exposure to Cobalt: A Population Toxicokinetic Modeling 
Approach Validated by Field Results Challenges the BEI® for Urinary Cobalt, A. Martin et al 
 
1. Toxicokinetic model 
 
 For each subject, the time course of cobalt excretion (in µg) in urine noted Qu, was 
modelled in a deterministic two-compartment model with central and peripheral 
compartments. Figure 1.1 presents that model graphically: arrows represent the flows between 
compartments or the external environment. Kin (in L/h)  conditions the quantity of cobalt 
inhaled (Cin in µg/L) entering the organism. Ke, Kr and Ks are transfer coefficients (in 1/h) and 
describe the flow between the compartments (Kr, Ks) or excretion (Ke). The corresponding 
half-times can be computed as ln(2)/Ki were i is either r, s or e. 
 
 
Figure 1.1 : The two-compartment model used. 
  
 The following differential equation system describes the temporal evolution of the 
quantities of cobalt quantities Qc, Qp and Qu in the central compartment, peripheral 





















u ⋅=  (A3) 
 Equation (A1) represents the instantaneous variation of the quantity of cobalt in the 
central compartment (that is the quantity entering in the compartment, minus the quantity 
leaving the it). Equation (A2) represents in the same way the instantaneous variation of the 
quantity of cobalt in the peripheral compartment. Equation (A3) gives the instantaneous 
variation of the quantity of cobalt excreted in urine. 
 The input parameter Kin, the transfer rate constants Kr and Ks, and the excretion rate 
constant Ke  have a specific value for each subject. 
 
2. Priors, model checking, cross validation 
Priors and posteriors 
 The Bayesian  framework in which our model was calibrated requires to specify priors 
for its parameters.  
 Figures 2.1 to 2.10 show the prior and posterior distribution of the population 
parameters. These Figures show clearly that the data have strongly modified the parameter 
distributions and that the priors are likely to have little influence on the final results. Of 
course, if prior knowledge on these parameters had been available in addition to the rough 
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Population Geometric Mean of Kin [L/h] 
Prior Posterior
Note : Normal prior with mean 300 and sd 200 truncated between 20 and 600
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Population Geometric Mean of Ke [1/h]
Prior Posterior
Note : Uniform prior between 0.0001 and 0.5
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Population Geometric Mean of Kr [1/h]
Prior Posterior
Note : Uniform prior between 0.0001 and 0.5
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Prior Posterior
Note : Uniform prior between 0.0001 and 0.5
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Coefficient of variation CoV [no unit]
Prior Posterior
Note : Uniform prior between 0.02 and 1
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 Constant error term SDmin [µg/void]
Prior Posterior
Note : Uniform prior between 0 and 5
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Population Geometric Standard Deviation of Kin [no unit]
Prior Posterior
Note : Normal prior with mean 2 and sd 2 truncated between 1 and 10
 








1 2 3 4 5 6 7 8 9 10
Population Geometric Standard Deviation of Ke [no unit]
Prior Posterior
Note : Normal prior with mean 2 and sd 2 truncated between 1 and 10
 









1 2 3 4 5 6 7 8 9 10
Population Geometric Standard Deviation of Kr [no unit]
Prior Posterior
Note : Normal prior with mean 2 and sd 2 truncated between 1 and 10
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Population Geometric Standard Deviation of Ks [no unit]
Prior Posterior
Note : Normal prior with mean 2 and sd 2 truncated between 1 and 10
 




 The fit of the model to the data was examined by plotting the observed vs predicted 
urinary and atmospheric measurements.  
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Model Predicted urinary cobalt  [µg/void]
 
Figure 2.11 : Scatter plot of observed and predicted  urinary data . 
 
 The corresponding coefficient of determination is 0.77 on the natural scale and 0.72 on 
the logarithmic scale. Although some of the measured values are below the corresponding 
predicted values, the overall fit seems adequate. Note that (with the possible exception of 
subject 9 which has one of the lowest atmospheric exposures) the various "outliers" 
correspond to different subjects. 
 For atmospheric measurements, one clearly sees the effect of rounding in the lower 
measurements.  The overall fit is however adequate. The corresponding coefficient of 


































































































































1 2 5 10 20 100
Model Predicted atmospheric cobalt  [µg/m3]
 
Figure 2.12 : Scatter plot of observed and predicted atmospheric data  
 
Cross-validation 
 To cross-validate the model it was first calibrated using 11 randomly selected subjects 
out of the 16 study subjects. Predictions of the data for the 5 subjects left out was examined 
by simulating 50 urinary samples based on their actual atmospheric exposure measurements 
and plotting the observed values together with the simulation results. Figure 2.13 shows an 
example for subject E. These results did not show any inconsistencies between model 
















Figure 2.13 : Fifty urinary simulations based on the subject E atmospheric measurements, 
with observed data. 
 
3. Comparison of ROC curves for various Urinary Sampling 
    Strategy (USS) 
 
 As explained in the main text, the USS were compared on the basis of their sensitivity 
and specificity in detecting an atmospheric value above a TLV of 20 μg/m3. For each USS, a 
receiver operating characteristic (ROC) curve, giving the sensitivity for detecting above TVL 
excursions as a function of (1 minus specificity), was constructed by varying the urinary 
decision threshold by steps of 0.25 μg/L between 0 and 9 μg/L and by steps of 1 μg/L 
between 10 and 20μg/L. For any given value of this threshold (say 8 μg/L)  the sensitivity 
was computed as the number of simulated USS-specific urinary exceeding  8 μg/L, divided by 
12x200=2400, the simulations corresponding to an atmospheric exposure equal to or 
exceeding the 20 μg/m3 TLV. Similarly the specificity was computed as the number of 
simulated USS-specific urinary below  8 μg/L, divided by 15x200=3000, the simulations 
corresponding to an atmospheric exposure below the 20 μg/m3 TLV.  
 Figure 3.1 shows the graphical comparison of these ROC curves. Five urinary 
sampling strategies (USS) were compared: (A) urine collected each day at the shift end, and 
averaged over four workdays; (B) urine collected each day after 4 hours of exposure, and 
averaged over four workdays; (C) first urine of the last day of the workweek; (D) urine from 
the last 3 hours of the last shift of the week; (E) urine from the 3 hours following the end of 
the last shift of the week. It is to be noted that the curves corresponding to the last two 
strategies USS (D) and (E) are virtually identical and are the ones with the maximal area 
























Figure 3.1 : Receiving Operator Curves of five urinary sampling strategies (USS). USS(A) 
corresponds to urine collected each day at the shift end, and averaged over four workdays; 
USS(B) corresponds to urine collected each day after 4 hours of exposure, and averaged over 
four workdays; USS(C) corresponds to first urine of the last day of the workweek; USS(D) 
corresponds to urine from the last 3 hours of the last shift of the week and USS(E) 
corresponds to urine from the 3 hours following the end of the last shift of the week. 
 
 Table 3.1 shows the areas under the curve for each of the strategies. As the these areas 
are between 0.70 and 0.76, there is no great difference between strategies. Strategy D 
however is virtually identical to the strategy recommended by the ACGIH, so that the fact that 
we found it to be the best is reassuring. 
 
Table 3.1 : Areas under the ROC curves corresponding to USS 
 Urinary Sampling 
 Strategies (USS) 
Areas under 
 the ROC curves 
(D) 0.76 
(E) 0.75 
(A) 0.73 
(C) 0.71 
(B) 0.70 
